Chapter 42. Vascular Access for Hemodialysis

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Kevan R. Polkinghorne MD

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch42

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Polkinghorne, K. R. (2008) Vascular Access for Hemodialysis, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch42

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Department of Nephrology, Monash Medical Centre, Melbourne, Australia

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391

SEARCH

Keywords:

  • vascular Access for HD;
  • RCTs assessing effect of access blood flow surveillance on access thrombosis rate;
  • DU stenosis screening;
  • pharmacological approaches to preventing AVF and AVG failure;
  • preventing cuffed CRB;
  • RCTs of prophylaxis of cuffed (tunneled) CRB in hemodialysis patients;
  • vascular access for hemodialysis - major components in treatment of end-stage renal disease patients

Summary

This chapter contains sections titled:

  • Introduction

  • Screening and vascular access survival

  • Pharmacological approaches to preventing AVF and AVG failure: RCTs

  • Preventing cuffed CRB: RCTs

  • Conclusions

  • References